𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

✍ Scribed by Meijer, D.; Sieuwerts, A. M; Look, M. P; van Agthoven, T.; Foekens, J. A; Dorssers, L. C J

Book ID
120352996
Publisher
Bioscientifica
Year
2008
Tongue
English
Weight
215 KB
Volume
15
Category
Article
ISSN
1351-0088

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a